Cross-sectional study investigates adipokines' associations with sarcopenia in older adults with CKM syndrome, suggesting potential diagnostic use.
OBJECTIVE: Adiponectin and leptin are key adipokines associated with adipose tissue and skeletal muscle metabolism. This study aimed to investigate the associations of adiponectin, leptin, and the adiponectin-to-leptin ratio (A/L ratio) with sarcopenia in older adults with cardiovascular-kidney-metabolic (CKM) syndrome. METHODS: This cross-sectional study included 632 older adults (70.60 ± 6.09 years; 56.8% female) with CKM syndrome stages 1-4. Sarcopenia was defined according to the Asian Working Group for Sarcopenia 2019 criteria. Plasma adiponectin and leptin were measured by ELISA and multiplex bead array, and were ln-transformed. Binary and multinomial logistic regression were used to analyze the associations of adiponectin, leptin, and the A/L ratio with sarcopenia, with adjustments for demographic characteristics, BMI, and health status. Receiver operating characteristic curves were used to evaluate the discriminative ability of adipokines. RESULTS: 256 (40.5%) and 57 (9.0%) participants had possible sarcopenia and sarcopenia, respectively. Binary logistic regression revealed that higher adiponectin was independently associated with higher odds of low physical function (OR = 2.11, 95% CI: 1.52-2.98); higher leptin with higher odds of low muscle mass (OR = 1.96, 95% CI: 1.26-3.08) and lower odds of low physical function (OR = 0.65, 95% CI: 0.49-0.87); and a higher A/L ratio with lower odds of low muscle mass (OR = 0.80, 95% CI: 0.65-0.98) but higher odds of low muscle strength (OR = 1.26, 95% CI: 1.06-1.50) and low physical function (OR = 1.24, 95% CI: 1.09-1.42) (all P < 0.05). In fully adjusted multinomial logistic regression, adipokines were significantly associated with possible sarcopenia but not with sarcopenia. A/L ratio showed significant AUC values for possible sarcopenia (AUC = 0.641, P < 0.001) and sarcopenia (AUC = 0.617, P = 0.004), with slightly higher performance in CKM stages 1-2 than in stages 3-4. CONCLUSIONS: Adiponectin, leptin, and the A/L ratio exhibit component-specific associations with sarcopenia in older adults with CKM syndrome. These adipokines may help identify sarcopenia status, particularly in early CKM stages.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: